In 2023, Rebecca Chambers earned $901.49K in total compensation at Veracyte, including $510.00K salary and $388.49K bonus. Most recently acquired 4,318 shares in Mar 2024. Currently holds stock worth $5.10M. 4+ years at the helm of Veracyte.
Compensation History
Annual executive compensation data for Rebecca Chambers, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$901.49K
Salary
$510.00K
Bonus
$388.49K
Other
$3.00K
Salary
$510.00KBoard Justification
The compensation program is designed to reward executives for performance aligned with the company's strategic goals and to attract and retain top talent.
Bonus
$388.49KBoard Justification
Annual cash incentive compensation based on achieving corporate goals, with a corporate multiplier of 138.5% for 2023 performance.
Other Compensation
$3.00KBoard Justification
Includes matching contributions to 401(k) plans.
Restricted Stock
Board Justification
No stock was reported as vested in 2023 for Rebecca Chambers.
Performance Metrics
Annual cash incentives tied to revenue and cash flow from operations.
Rebecca Chambers
CEO of Veracyte
Education
B.S. from John Carroll University and an M.B.A. from Cornell University.
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
January 1, 1978 - 47 years ago
CEO of Veracyte for
4 years 4 months (Jul 2021 - Present)
Previous Experience
Chief Financial Officer of Outset Medical, Inc. and various roles at Illumina, Inc.
Other Veracyte CEOs
Holdings
Track Rebecca Chambers's stock holdings and portfolio value over time.
Insider Trading
Rebecca Chambers's recent stock transactions, purchases, and sales filed with the SEC.
4,318 shares
VCYT
Mar 15, 2024
Received
59,856 shares
VCYT
Mar 6, 2024
Received
26,014 shares
VCYT
Mar 6, 2023
Received
21,404 shares
VCYT
Aug 5, 2022
Received
20,728 shares
VCYT
Mar 3, 2022
Received
34,000 shares
VCYT
Jul 19, 2021
Received
Rivals
Compare Rebecca Chambers with competitor CEOs and industry peers.
John Evans
CEO of Beam Therapeutics
2023 Compensation
Stock
$0.00
Salary
$685.00K
Bonus
$431.55K
Other
$17.68K
Total Holdings
$2.47M
Kimberly J. Popovits
CEO of 10x Genomics, Inc.
2023 Compensation
Stock
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Total Holdings
$286.13K
Chad Robins
Founder and CEO of Adaptive Biotechnologies
2023 Compensation
Stock
$716.86K
Salary
$663.00K
Bonus
$318.24K
Other
$22.32K
Total Holdings
$118.69M
AmirAli Talasaz
Founder and CEO of Guardant Health
2023 Compensation
Stock
$0.00
Salary
$1.00
Bonus
$0.00
Other
$26.41K
Total Holdings
$11.66M